Global Immunoisolation Cell Encapsulation Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Immunoisolation Cell Encapsulation Device market size was valued at US$ 121 million in 2025 and is forecast to a readjusted size of US$ 275 million by 2032 with a CAGR of 12.2% during review period.
An immunoisolation cell encapsulation device is a cell therapy delivery device that separates therapeutic living cells from the host immune system through semipermeable membranes, microcapsules, hydrogels, or implantable chambers while allowing exchange of oxygen, nutrients, metabolic waste, and therapeutic molecules. It is mainly used for islet cell replacement, sustained secretion from engineered cells, allogeneic or xenogeneic cell transplantation, and preclinical cell therapy evaluation. Product value comes from material biocompatibility, pore-size and mass-transfer control, cell viability maintenance, retrievability, GMP manufacturing, and regulatory validation as a combination product, with an estimated gross margin of about 55%.
Downstream demand is mainly driven by type 1 diabetes cell replacement therapy, allogeneic cell therapy, and engineered cell platforms that can provide long-term secretion of therapeutic proteins. Compared with direct cell infusion, immunoisolation devices can reduce reliance on systemic immunosuppression and provide a more controllable engineered carrier for cell dose, implantation site, and safe retrieval, making them suitable for standardized combination products led by major pharmaceutical and regenerative medicine companies.
Product upgrades are focused on high-throughput mass transfer, anti-fibrotic materials, local immunomodulation, oxygenation design, and prevascularized structures. The supplier landscape is still led by European and North American innovation companies and translational medicine teams, with limited commercialized products. Companies typically build barriers through proprietary materials, device architecture, cell source know-how, and clinical data, and future scale-up is more likely to occur through pharmaceutical partnerships, licensing, or acquisitions.
Key opportunities come from diabetes, endocrine replacement, sustained protein/enzyme delivery, and localized cancer cell therapy, but risks remain high, including foreign body response, hypoxia, batch consistency, implantation workflow, long-term follow-up, and combination-product regulatory requirements. Suppliers with GMP manufacturing, retrievable device design, and integrated cell-material validation capabilities are better positioned to enter clinical programs.
This report is a detailed and comprehensive analysis for global Immunoisolation Cell Encapsulation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immunoisolation Cell Encapsulation Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Immunoisolation Cell Encapsulation Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Immunoisolation Cell Encapsulation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immunoisolation Cell Encapsulation Device, with price, sales quantity, revenue, and global market share of Immunoisolation Cell Encapsulation Device from 2021 to 2026.
Chapter 3, the Immunoisolation Cell Encapsulation Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunoisolation Cell Encapsulation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Immunoisolation Cell Encapsulation Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immunoisolation Cell Encapsulation Device.
Chapter 14 and 15, to describe Immunoisolation Cell Encapsulation Device sales channel, distributors, customers, research findings and conclusion.
An immunoisolation cell encapsulation device is a cell therapy delivery device that separates therapeutic living cells from the host immune system through semipermeable membranes, microcapsules, hydrogels, or implantable chambers while allowing exchange of oxygen, nutrients, metabolic waste, and therapeutic molecules. It is mainly used for islet cell replacement, sustained secretion from engineered cells, allogeneic or xenogeneic cell transplantation, and preclinical cell therapy evaluation. Product value comes from material biocompatibility, pore-size and mass-transfer control, cell viability maintenance, retrievability, GMP manufacturing, and regulatory validation as a combination product, with an estimated gross margin of about 55%.
Downstream demand is mainly driven by type 1 diabetes cell replacement therapy, allogeneic cell therapy, and engineered cell platforms that can provide long-term secretion of therapeutic proteins. Compared with direct cell infusion, immunoisolation devices can reduce reliance on systemic immunosuppression and provide a more controllable engineered carrier for cell dose, implantation site, and safe retrieval, making them suitable for standardized combination products led by major pharmaceutical and regenerative medicine companies.
Product upgrades are focused on high-throughput mass transfer, anti-fibrotic materials, local immunomodulation, oxygenation design, and prevascularized structures. The supplier landscape is still led by European and North American innovation companies and translational medicine teams, with limited commercialized products. Companies typically build barriers through proprietary materials, device architecture, cell source know-how, and clinical data, and future scale-up is more likely to occur through pharmaceutical partnerships, licensing, or acquisitions.
Key opportunities come from diabetes, endocrine replacement, sustained protein/enzyme delivery, and localized cancer cell therapy, but risks remain high, including foreign body response, hypoxia, batch consistency, implantation workflow, long-term follow-up, and combination-product regulatory requirements. Suppliers with GMP manufacturing, retrievable device design, and integrated cell-material validation capabilities are better positioned to enter clinical programs.
This report is a detailed and comprehensive analysis for global Immunoisolation Cell Encapsulation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immunoisolation Cell Encapsulation Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Immunoisolation Cell Encapsulation Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Immunoisolation Cell Encapsulation Device
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Immunoisolation Cell Encapsulation Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Microcapsule Encapsulation Devices
- Sheet and Pouch Macroencapsulation Devices
- Hollow-Fiber Encapsulation Devices
- Chamber Encapsulation Devices
- Conformal Coating Encapsulation Devices
- Size-Selective Semipermeable Membrane
- Hydrogel Matrix Barrier
- Cellulose Sulfate Polymer Capsule
- Local Immunomodulation Barrier
- Nanoporous Membrane Barrier
- Human Donor Islets
- Stem Cell-Derived Islet Cells
- Porcine Islet Cells
- Engineered Therapeutic Cells
- Stem Cells and Stromal Cells
- Other Therapeutic Cells
- Passive Diffusion Design
- Prevascularized Design
- Oxygen-Refueled Design
- Oxygen-Generating Design
- Port-Accessible Refillable Design
- Type 1 Diabetes Cell Therapy
- Metabolic and Endocrine Replacement
- Protein and Enzyme Delivery
- Cancer Local Cell Therapy
- Cell Therapy R&D and Preclinical Evaluation
- Bioreactor Cell Protection
- Other Applications
- Vertex Pharmaceuticals
- Sernova
- Defymed
- TheraCyte
- Austrianova
- Diatranz Otsuka
- Otsuka Pharmaceutical Factory
- Procyon Technologies
- Novo Nordisk
- Eli Lilly
- PharmaCyte Biotech
- Beta-O2 Technologies
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Immunoisolation Cell Encapsulation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immunoisolation Cell Encapsulation Device, with price, sales quantity, revenue, and global market share of Immunoisolation Cell Encapsulation Device from 2021 to 2026.
Chapter 3, the Immunoisolation Cell Encapsulation Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunoisolation Cell Encapsulation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Immunoisolation Cell Encapsulation Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immunoisolation Cell Encapsulation Device.
Chapter 14 and 15, to describe Immunoisolation Cell Encapsulation Device sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Microcapsule Encapsulation Devices
1.3.3 Sheet and Pouch Macroencapsulation Devices
1.3.4 Hollow-Fiber Encapsulation Devices
1.3.5 Chamber Encapsulation Devices
1.3.6 Conformal Coating Encapsulation Devices
1.4 Market Analysis by Immunoisolation Mechanism
1.4.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Immunoisolation Mechanism: 2021 Versus 2025 Versus 2032
1.4.2 Size-Selective Semipermeable Membrane
1.4.3 Hydrogel Matrix Barrier
1.4.4 Cellulose Sulfate Polymer Capsule
1.4.5 Local Immunomodulation Barrier
1.4.6 Nanoporous Membrane Barrier
1.5 Market Analysis by Cell Source
1.5.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Cell Source: 2021 Versus 2025 Versus 2032
1.5.2 Human Donor Islets
1.5.3 Stem Cell-Derived Islet Cells
1.5.4 Porcine Islet Cells
1.5.5 Engineered Therapeutic Cells
1.5.6 Stem Cells and Stromal Cells
1.5.7 Other Therapeutic Cells
1.6 Market Analysis by Oxygenation and Vascularization Design
1.6.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Oxygenation and Vascularization Design: 2021 Versus 2025 Versus 2032
1.6.2 Passive Diffusion Design
1.6.3 Prevascularized Design
1.6.4 Oxygen-Refueled Design
1.6.5 Oxygen-Generating Design
1.6.6 Port-Accessible Refillable Design
1.7 Market Analysis by Application
1.7.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Type 1 Diabetes Cell Therapy
1.7.3 Metabolic and Endocrine Replacement
1.7.4 Protein and Enzyme Delivery
1.7.5 Cancer Local Cell Therapy
1.7.6 Cell Therapy R&D and Preclinical Evaluation
1.7.7 Bioreactor Cell Protection
1.7.8 Other Applications
1.8 Global Immunoisolation Cell Encapsulation Device Market Size & Forecast
1.8.1 Global Immunoisolation Cell Encapsulation Device Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Immunoisolation Cell Encapsulation Device Sales Quantity (2021-2032)
1.8.3 Global Immunoisolation Cell Encapsulation Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Vertex Pharmaceuticals
2.1.1 Vertex Pharmaceuticals Details
2.1.2 Vertex Pharmaceuticals Major Business
2.1.3 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product and Services
2.1.4 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Vertex Pharmaceuticals Recent Developments/Updates
2.2 Sernova
2.2.1 Sernova Details
2.2.2 Sernova Major Business
2.2.3 Sernova Immunoisolation Cell Encapsulation Device Product and Services
2.2.4 Sernova Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sernova Recent Developments/Updates
2.3 Defymed
2.3.1 Defymed Details
2.3.2 Defymed Major Business
2.3.3 Defymed Immunoisolation Cell Encapsulation Device Product and Services
2.3.4 Defymed Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Defymed Recent Developments/Updates
2.4 TheraCyte
2.4.1 TheraCyte Details
2.4.2 TheraCyte Major Business
2.4.3 TheraCyte Immunoisolation Cell Encapsulation Device Product and Services
2.4.4 TheraCyte Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 TheraCyte Recent Developments/Updates
2.5 Austrianova
2.5.1 Austrianova Details
2.5.2 Austrianova Major Business
2.5.3 Austrianova Immunoisolation Cell Encapsulation Device Product and Services
2.5.4 Austrianova Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Austrianova Recent Developments/Updates
2.6 Diatranz Otsuka
2.6.1 Diatranz Otsuka Details
2.6.2 Diatranz Otsuka Major Business
2.6.3 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product and Services
2.6.4 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Diatranz Otsuka Recent Developments/Updates
2.7 Otsuka Pharmaceutical Factory
2.7.1 Otsuka Pharmaceutical Factory Details
2.7.2 Otsuka Pharmaceutical Factory Major Business
2.7.3 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product and Services
2.7.4 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Otsuka Pharmaceutical Factory Recent Developments/Updates
2.8 Procyon Technologies
2.8.1 Procyon Technologies Details
2.8.2 Procyon Technologies Major Business
2.8.3 Procyon Technologies Immunoisolation Cell Encapsulation Device Product and Services
2.8.4 Procyon Technologies Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Procyon Technologies Recent Developments/Updates
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Immunoisolation Cell Encapsulation Device Product and Services
2.9.4 Novo Nordisk Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novo Nordisk Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Immunoisolation Cell Encapsulation Device Product and Services
2.10.4 Eli Lilly Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 PharmaCyte Biotech
2.11.1 PharmaCyte Biotech Details
2.11.2 PharmaCyte Biotech Major Business
2.11.3 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product and Services
2.11.4 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 PharmaCyte Biotech Recent Developments/Updates
2.12 Beta-O2 Technologies
2.12.1 Beta-O2 Technologies Details
2.12.2 Beta-O2 Technologies Major Business
2.12.3 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product and Services
2.12.4 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Beta-O2 Technologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY MANUFACTURER
3.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Immunoisolation Cell Encapsulation Device Revenue by Manufacturer (2021-2026)
3.3 Global Immunoisolation Cell Encapsulation Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Immunoisolation Cell Encapsulation Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Immunoisolation Cell Encapsulation Device Manufacturer Market Share in 2025
3.4.3 Top 6 Immunoisolation Cell Encapsulation Device Manufacturer Market Share in 2025
3.5 Immunoisolation Cell Encapsulation Device Market: Overall Company Footprint Analysis
3.5.1 Immunoisolation Cell Encapsulation Device Market: Region Footprint
3.5.2 Immunoisolation Cell Encapsulation Device Market: Company Product Type Footprint
3.5.3 Immunoisolation Cell Encapsulation Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immunoisolation Cell Encapsulation Device Market Size by Region
4.1.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2032)
4.1.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2032)
4.1.3 Global Immunoisolation Cell Encapsulation Device Average Price by Region (2021-2032)
4.2 North America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.3 Europe Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.4 Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.5 South America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.6 Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
5.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2021-2032)
5.3 Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
6.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2021-2032)
6.3 Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
7.2 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
7.3 North America Immunoisolation Cell Encapsulation Device Market Size by Country
7.3.1 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
7.3.2 North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
8.2 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
8.3 Europe Immunoisolation Cell Encapsulation Device Market Size by Country
8.3.1 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Immunoisolation Cell Encapsulation Device Market Size by Region
9.3.1 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
10.2 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
10.3 South America Immunoisolation Cell Encapsulation Device Market Size by Country
10.3.1 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
10.3.2 South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Immunoisolation Cell Encapsulation Device Market Size by Country
11.3.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Immunoisolation Cell Encapsulation Device Market Drivers
12.2 Immunoisolation Cell Encapsulation Device Market Restraints
12.3 Immunoisolation Cell Encapsulation Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immunoisolation Cell Encapsulation Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immunoisolation Cell Encapsulation Device
13.3 Immunoisolation Cell Encapsulation Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immunoisolation Cell Encapsulation Device Typical Distributors
14.3 Immunoisolation Cell Encapsulation Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Microcapsule Encapsulation Devices
1.3.3 Sheet and Pouch Macroencapsulation Devices
1.3.4 Hollow-Fiber Encapsulation Devices
1.3.5 Chamber Encapsulation Devices
1.3.6 Conformal Coating Encapsulation Devices
1.4 Market Analysis by Immunoisolation Mechanism
1.4.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Immunoisolation Mechanism: 2021 Versus 2025 Versus 2032
1.4.2 Size-Selective Semipermeable Membrane
1.4.3 Hydrogel Matrix Barrier
1.4.4 Cellulose Sulfate Polymer Capsule
1.4.5 Local Immunomodulation Barrier
1.4.6 Nanoporous Membrane Barrier
1.5 Market Analysis by Cell Source
1.5.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Cell Source: 2021 Versus 2025 Versus 2032
1.5.2 Human Donor Islets
1.5.3 Stem Cell-Derived Islet Cells
1.5.4 Porcine Islet Cells
1.5.5 Engineered Therapeutic Cells
1.5.6 Stem Cells and Stromal Cells
1.5.7 Other Therapeutic Cells
1.6 Market Analysis by Oxygenation and Vascularization Design
1.6.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Oxygenation and Vascularization Design: 2021 Versus 2025 Versus 2032
1.6.2 Passive Diffusion Design
1.6.3 Prevascularized Design
1.6.4 Oxygen-Refueled Design
1.6.5 Oxygen-Generating Design
1.6.6 Port-Accessible Refillable Design
1.7 Market Analysis by Application
1.7.1 Overview: Global Immunoisolation Cell Encapsulation Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Type 1 Diabetes Cell Therapy
1.7.3 Metabolic and Endocrine Replacement
1.7.4 Protein and Enzyme Delivery
1.7.5 Cancer Local Cell Therapy
1.7.6 Cell Therapy R&D and Preclinical Evaluation
1.7.7 Bioreactor Cell Protection
1.7.8 Other Applications
1.8 Global Immunoisolation Cell Encapsulation Device Market Size & Forecast
1.8.1 Global Immunoisolation Cell Encapsulation Device Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Immunoisolation Cell Encapsulation Device Sales Quantity (2021-2032)
1.8.3 Global Immunoisolation Cell Encapsulation Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Vertex Pharmaceuticals
2.1.1 Vertex Pharmaceuticals Details
2.1.2 Vertex Pharmaceuticals Major Business
2.1.3 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product and Services
2.1.4 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Vertex Pharmaceuticals Recent Developments/Updates
2.2 Sernova
2.2.1 Sernova Details
2.2.2 Sernova Major Business
2.2.3 Sernova Immunoisolation Cell Encapsulation Device Product and Services
2.2.4 Sernova Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sernova Recent Developments/Updates
2.3 Defymed
2.3.1 Defymed Details
2.3.2 Defymed Major Business
2.3.3 Defymed Immunoisolation Cell Encapsulation Device Product and Services
2.3.4 Defymed Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Defymed Recent Developments/Updates
2.4 TheraCyte
2.4.1 TheraCyte Details
2.4.2 TheraCyte Major Business
2.4.3 TheraCyte Immunoisolation Cell Encapsulation Device Product and Services
2.4.4 TheraCyte Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 TheraCyte Recent Developments/Updates
2.5 Austrianova
2.5.1 Austrianova Details
2.5.2 Austrianova Major Business
2.5.3 Austrianova Immunoisolation Cell Encapsulation Device Product and Services
2.5.4 Austrianova Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Austrianova Recent Developments/Updates
2.6 Diatranz Otsuka
2.6.1 Diatranz Otsuka Details
2.6.2 Diatranz Otsuka Major Business
2.6.3 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product and Services
2.6.4 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Diatranz Otsuka Recent Developments/Updates
2.7 Otsuka Pharmaceutical Factory
2.7.1 Otsuka Pharmaceutical Factory Details
2.7.2 Otsuka Pharmaceutical Factory Major Business
2.7.3 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product and Services
2.7.4 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Otsuka Pharmaceutical Factory Recent Developments/Updates
2.8 Procyon Technologies
2.8.1 Procyon Technologies Details
2.8.2 Procyon Technologies Major Business
2.8.3 Procyon Technologies Immunoisolation Cell Encapsulation Device Product and Services
2.8.4 Procyon Technologies Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Procyon Technologies Recent Developments/Updates
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Immunoisolation Cell Encapsulation Device Product and Services
2.9.4 Novo Nordisk Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novo Nordisk Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Immunoisolation Cell Encapsulation Device Product and Services
2.10.4 Eli Lilly Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 PharmaCyte Biotech
2.11.1 PharmaCyte Biotech Details
2.11.2 PharmaCyte Biotech Major Business
2.11.3 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product and Services
2.11.4 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 PharmaCyte Biotech Recent Developments/Updates
2.12 Beta-O2 Technologies
2.12.1 Beta-O2 Technologies Details
2.12.2 Beta-O2 Technologies Major Business
2.12.3 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product and Services
2.12.4 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Beta-O2 Technologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY MANUFACTURER
3.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Immunoisolation Cell Encapsulation Device Revenue by Manufacturer (2021-2026)
3.3 Global Immunoisolation Cell Encapsulation Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Immunoisolation Cell Encapsulation Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Immunoisolation Cell Encapsulation Device Manufacturer Market Share in 2025
3.4.3 Top 6 Immunoisolation Cell Encapsulation Device Manufacturer Market Share in 2025
3.5 Immunoisolation Cell Encapsulation Device Market: Overall Company Footprint Analysis
3.5.1 Immunoisolation Cell Encapsulation Device Market: Region Footprint
3.5.2 Immunoisolation Cell Encapsulation Device Market: Company Product Type Footprint
3.5.3 Immunoisolation Cell Encapsulation Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immunoisolation Cell Encapsulation Device Market Size by Region
4.1.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2032)
4.1.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2032)
4.1.3 Global Immunoisolation Cell Encapsulation Device Average Price by Region (2021-2032)
4.2 North America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.3 Europe Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.4 Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.5 South America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
4.6 Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
5.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2021-2032)
5.3 Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
6.2 Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2021-2032)
6.3 Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
7.2 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
7.3 North America Immunoisolation Cell Encapsulation Device Market Size by Country
7.3.1 North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
7.3.2 North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
8.2 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
8.3 Europe Immunoisolation Cell Encapsulation Device Market Size by Country
8.3.1 Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Immunoisolation Cell Encapsulation Device Market Size by Region
9.3.1 Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
10.2 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
10.3 South America Immunoisolation Cell Encapsulation Device Market Size by Country
10.3.1 South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
10.3.2 South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Immunoisolation Cell Encapsulation Device Market Size by Country
11.3.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Immunoisolation Cell Encapsulation Device Market Drivers
12.2 Immunoisolation Cell Encapsulation Device Market Restraints
12.3 Immunoisolation Cell Encapsulation Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immunoisolation Cell Encapsulation Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immunoisolation Cell Encapsulation Device
13.3 Immunoisolation Cell Encapsulation Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immunoisolation Cell Encapsulation Device Typical Distributors
14.3 Immunoisolation Cell Encapsulation Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Immunoisolation Cell Encapsulation Device Consumption Value by Immunoisolation Mechanism, (USD Million), 2021 & 2025 & 2032
Table 3. Global Immunoisolation Cell Encapsulation Device Consumption Value by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 4. Global Immunoisolation Cell Encapsulation Device Consumption Value by Oxygenation and Vascularization Design, (USD Million), 2021 & 2025 & 2032
Table 5. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 7. Vertex Pharmaceuticals Major Business
Table 8. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product and Services
Table 9. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Vertex Pharmaceuticals Recent Developments/Updates
Table 11. Sernova Basic Information, Manufacturing Base and Competitors
Table 12. Sernova Major Business
Table 13. Sernova Immunoisolation Cell Encapsulation Device Product and Services
Table 14. Sernova Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Sernova Recent Developments/Updates
Table 16. Defymed Basic Information, Manufacturing Base and Competitors
Table 17. Defymed Major Business
Table 18. Defymed Immunoisolation Cell Encapsulation Device Product and Services
Table 19. Defymed Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Defymed Recent Developments/Updates
Table 21. TheraCyte Basic Information, Manufacturing Base and Competitors
Table 22. TheraCyte Major Business
Table 23. TheraCyte Immunoisolation Cell Encapsulation Device Product and Services
Table 24. TheraCyte Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. TheraCyte Recent Developments/Updates
Table 26. Austrianova Basic Information, Manufacturing Base and Competitors
Table 27. Austrianova Major Business
Table 28. Austrianova Immunoisolation Cell Encapsulation Device Product and Services
Table 29. Austrianova Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Austrianova Recent Developments/Updates
Table 31. Diatranz Otsuka Basic Information, Manufacturing Base and Competitors
Table 32. Diatranz Otsuka Major Business
Table 33. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product and Services
Table 34. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Diatranz Otsuka Recent Developments/Updates
Table 36. Otsuka Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 37. Otsuka Pharmaceutical Factory Major Business
Table 38. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product and Services
Table 39. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Otsuka Pharmaceutical Factory Recent Developments/Updates
Table 41. Procyon Technologies Basic Information, Manufacturing Base and Competitors
Table 42. Procyon Technologies Major Business
Table 43. Procyon Technologies Immunoisolation Cell Encapsulation Device Product and Services
Table 44. Procyon Technologies Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Procyon Technologies Recent Developments/Updates
Table 46. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 47. Novo Nordisk Major Business
Table 48. Novo Nordisk Immunoisolation Cell Encapsulation Device Product and Services
Table 49. Novo Nordisk Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Novo Nordisk Recent Developments/Updates
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Immunoisolation Cell Encapsulation Device Product and Services
Table 54. Eli Lilly Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Eli Lilly Recent Developments/Updates
Table 56. PharmaCyte Biotech Basic Information, Manufacturing Base and Competitors
Table 57. PharmaCyte Biotech Major Business
Table 58. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product and Services
Table 59. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. PharmaCyte Biotech Recent Developments/Updates
Table 61. Beta-O2 Technologies Basic Information, Manufacturing Base and Competitors
Table 62. Beta-O2 Technologies Major Business
Table 63. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product and Services
Table 64. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Beta-O2 Technologies Recent Developments/Updates
Table 66. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 67. Global Immunoisolation Cell Encapsulation Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 68. Global Immunoisolation Cell Encapsulation Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 69. Market Position of Manufacturers in Immunoisolation Cell Encapsulation Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 70. Head Office and Immunoisolation Cell Encapsulation Device Production Site of Key Manufacturer
Table 71. Immunoisolation Cell Encapsulation Device Market: Company Product Type Footprint
Table 72. Immunoisolation Cell Encapsulation Device Market: Company Product Application Footprint
Table 73. Immunoisolation Cell Encapsulation Device New Market Entrants and Barriers to Market Entry
Table 74. Immunoisolation Cell Encapsulation Device Mergers, Acquisition, Agreements, and Collaborations
Table 75. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 76. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2026) & (Units)
Table 77. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2027-2032) & (Units)
Table 78. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 79. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2027-2032) & (USD Million)
Table 80. Global Immunoisolation Cell Encapsulation Device Average Price by Region (2021-2026) & (US$/Unit)
Table 81. Global Immunoisolation Cell Encapsulation Device Average Price by Region (2027-2032) & (US$/Unit)
Table 82. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 83. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 84. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2026) & (US$/Unit)
Table 87. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2027-2032) & (US$/Unit)
Table 88. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 89. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 90. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2021-2026) & (USD Million)
Table 91. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2027-2032) & (USD Million)
Table 92. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2026) & (US$/Unit)
Table 93. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2027-2032) & (US$/Unit)
Table 94. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 95. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 96. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 97. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 98. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 99. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 100. North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 101. North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 103. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 104. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 105. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 106. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 107. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 108. Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 109. Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 111. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 112. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 113. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 114. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2026) & (Units)
Table 115. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2027-2032) & (Units)
Table 116. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 117. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2027-2032) & (USD Million)
Table 118. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 119. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 120. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 121. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 122. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 123. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 124. South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 125. South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 127. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 128. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 129. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 130. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 131. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 132. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 133. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Immunoisolation Cell Encapsulation Device Raw Material
Table 135. Key Manufacturers of Immunoisolation Cell Encapsulation Device Raw Materials
Table 136. Immunoisolation Cell Encapsulation Device Typical Distributors
Table 137. Immunoisolation Cell Encapsulation Device Typical Customers
Table 1. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Immunoisolation Cell Encapsulation Device Consumption Value by Immunoisolation Mechanism, (USD Million), 2021 & 2025 & 2032
Table 3. Global Immunoisolation Cell Encapsulation Device Consumption Value by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 4. Global Immunoisolation Cell Encapsulation Device Consumption Value by Oxygenation and Vascularization Design, (USD Million), 2021 & 2025 & 2032
Table 5. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 7. Vertex Pharmaceuticals Major Business
Table 8. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product and Services
Table 9. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Vertex Pharmaceuticals Recent Developments/Updates
Table 11. Sernova Basic Information, Manufacturing Base and Competitors
Table 12. Sernova Major Business
Table 13. Sernova Immunoisolation Cell Encapsulation Device Product and Services
Table 14. Sernova Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Sernova Recent Developments/Updates
Table 16. Defymed Basic Information, Manufacturing Base and Competitors
Table 17. Defymed Major Business
Table 18. Defymed Immunoisolation Cell Encapsulation Device Product and Services
Table 19. Defymed Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Defymed Recent Developments/Updates
Table 21. TheraCyte Basic Information, Manufacturing Base and Competitors
Table 22. TheraCyte Major Business
Table 23. TheraCyte Immunoisolation Cell Encapsulation Device Product and Services
Table 24. TheraCyte Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. TheraCyte Recent Developments/Updates
Table 26. Austrianova Basic Information, Manufacturing Base and Competitors
Table 27. Austrianova Major Business
Table 28. Austrianova Immunoisolation Cell Encapsulation Device Product and Services
Table 29. Austrianova Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Austrianova Recent Developments/Updates
Table 31. Diatranz Otsuka Basic Information, Manufacturing Base and Competitors
Table 32. Diatranz Otsuka Major Business
Table 33. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product and Services
Table 34. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Diatranz Otsuka Recent Developments/Updates
Table 36. Otsuka Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 37. Otsuka Pharmaceutical Factory Major Business
Table 38. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product and Services
Table 39. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Otsuka Pharmaceutical Factory Recent Developments/Updates
Table 41. Procyon Technologies Basic Information, Manufacturing Base and Competitors
Table 42. Procyon Technologies Major Business
Table 43. Procyon Technologies Immunoisolation Cell Encapsulation Device Product and Services
Table 44. Procyon Technologies Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Procyon Technologies Recent Developments/Updates
Table 46. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 47. Novo Nordisk Major Business
Table 48. Novo Nordisk Immunoisolation Cell Encapsulation Device Product and Services
Table 49. Novo Nordisk Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Novo Nordisk Recent Developments/Updates
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Immunoisolation Cell Encapsulation Device Product and Services
Table 54. Eli Lilly Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Eli Lilly Recent Developments/Updates
Table 56. PharmaCyte Biotech Basic Information, Manufacturing Base and Competitors
Table 57. PharmaCyte Biotech Major Business
Table 58. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product and Services
Table 59. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. PharmaCyte Biotech Recent Developments/Updates
Table 61. Beta-O2 Technologies Basic Information, Manufacturing Base and Competitors
Table 62. Beta-O2 Technologies Major Business
Table 63. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product and Services
Table 64. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Beta-O2 Technologies Recent Developments/Updates
Table 66. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 67. Global Immunoisolation Cell Encapsulation Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 68. Global Immunoisolation Cell Encapsulation Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 69. Market Position of Manufacturers in Immunoisolation Cell Encapsulation Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 70. Head Office and Immunoisolation Cell Encapsulation Device Production Site of Key Manufacturer
Table 71. Immunoisolation Cell Encapsulation Device Market: Company Product Type Footprint
Table 72. Immunoisolation Cell Encapsulation Device Market: Company Product Application Footprint
Table 73. Immunoisolation Cell Encapsulation Device New Market Entrants and Barriers to Market Entry
Table 74. Immunoisolation Cell Encapsulation Device Mergers, Acquisition, Agreements, and Collaborations
Table 75. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 76. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2026) & (Units)
Table 77. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2027-2032) & (Units)
Table 78. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 79. Global Immunoisolation Cell Encapsulation Device Consumption Value by Region (2027-2032) & (USD Million)
Table 80. Global Immunoisolation Cell Encapsulation Device Average Price by Region (2021-2026) & (US$/Unit)
Table 81. Global Immunoisolation Cell Encapsulation Device Average Price by Region (2027-2032) & (US$/Unit)
Table 82. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 83. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 84. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Global Immunoisolation Cell Encapsulation Device Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2026) & (US$/Unit)
Table 87. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2027-2032) & (US$/Unit)
Table 88. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 89. Global Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 90. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2021-2026) & (USD Million)
Table 91. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application (2027-2032) & (USD Million)
Table 92. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2026) & (US$/Unit)
Table 93. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2027-2032) & (US$/Unit)
Table 94. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 95. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 96. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 97. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 98. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 99. North America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 100. North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 101. North America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 103. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 104. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 105. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 106. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 107. Europe Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 108. Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 109. Europe Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 111. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 112. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 113. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 114. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2021-2026) & (Units)
Table 115. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity by Region (2027-2032) & (Units)
Table 116. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 117. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value by Region (2027-2032) & (USD Million)
Table 118. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 119. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 120. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 121. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 122. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 123. South America Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 124. South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 125. South America Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2021-2026) & (Units)
Table 127. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Type (2027-2032) & (Units)
Table 128. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2021-2026) & (Units)
Table 129. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Application (2027-2032) & (Units)
Table 130. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2021-2026) & (Units)
Table 131. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity by Country (2027-2032) & (Units)
Table 132. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2021-2026) & (USD Million)
Table 133. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Immunoisolation Cell Encapsulation Device Raw Material
Table 135. Key Manufacturers of Immunoisolation Cell Encapsulation Device Raw Materials
Table 136. Immunoisolation Cell Encapsulation Device Typical Distributors
Table 137. Immunoisolation Cell Encapsulation Device Typical Customers
LIST OF FIGURES
Figure 1. Immunoisolation Cell Encapsulation Device Picture
Figure 2. Global Immunoisolation Cell Encapsulation Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type in 2025
Figure 4. Microcapsule Encapsulation Devices Examples
Figure 5. Sheet and Pouch Macroencapsulation Devices Examples
Figure 6. Hollow-Fiber Encapsulation Devices Examples
Figure 7. Chamber Encapsulation Devices Examples
Figure 8. Conformal Coating Encapsulation Devices Examples
Figure 9. Global Immunoisolation Cell Encapsulation Device Revenue by Immunoisolation Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism in 2025
Figure 11. Size-Selective Semipermeable Membrane Examples
Figure 12. Hydrogel Matrix Barrier Examples
Figure 13. Cellulose Sulfate Polymer Capsule Examples
Figure 14. Local Immunomodulation Barrier Examples
Figure 15. Nanoporous Membrane Barrier Examples
Figure 16. Global Immunoisolation Cell Encapsulation Device Revenue by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source in 2025
Figure 18. Human Donor Islets Examples
Figure 19. Stem Cell-Derived Islet Cells Examples
Figure 20. Porcine Islet Cells Examples
Figure 21. Engineered Therapeutic Cells Examples
Figure 22. Stem Cells and Stromal Cells Examples
Figure 23. Other Therapeutic Cells Examples
Figure 24. Global Immunoisolation Cell Encapsulation Device Revenue by Oxygenation and Vascularization Design, (USD Million), 2021 & 2025 & 2032
Figure 25. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design in 2025
Figure 26. Passive Diffusion Design Examples
Figure 27. Prevascularized Design Examples
Figure 28. Oxygen-Refueled Design Examples
Figure 29. Oxygen-Generating Design Examples
Figure 30. Port-Accessible Refillable Design Examples
Figure 31. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application in 2025
Figure 33. Type 1 Diabetes Cell Therapy Examples
Figure 34. Metabolic and Endocrine Replacement Examples
Figure 35. Protein and Enzyme Delivery Examples
Figure 36. Cancer Local Cell Therapy Examples
Figure 37. Cell Therapy R&D and Preclinical Evaluation Examples
Figure 38. Bioreactor Cell Protection Examples
Figure 39. Other Applications Examples
Figure 40. Global Immunoisolation Cell Encapsulation Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 41. Global Immunoisolation Cell Encapsulation Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 42. Global Immunoisolation Cell Encapsulation Device Sales Quantity (2021-2032) & (Units)
Figure 43. Global Immunoisolation Cell Encapsulation Device Price (2021-2032) & (US$/Unit)
Figure 44. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Manufacturer in 2025
Figure 45. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Manufacturer in 2025
Figure 46. Producer Shipments of Immunoisolation Cell Encapsulation Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 47. Top 3 Immunoisolation Cell Encapsulation Device Manufacturer (Revenue) Market Share in 2025
Figure 48. Top 6 Immunoisolation Cell Encapsulation Device Manufacturer (Revenue) Market Share in 2025
Figure 49. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Region (2021-2032)
Figure 50. Global Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Region (2021-2032)
Figure 51. North America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 52. Europe Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 53. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 55. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 56. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 57. Global Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Type (2021-2032)
Figure 58. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 59. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 60. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application (2021-2032)
Figure 61. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 62. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 63. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 64. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 65. North America Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 66. United States Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Canada Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Mexico Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 69. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 70. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 71. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 72. Europe Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 73. Germany Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 74. France Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 75. United Kingdom Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Russia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 77. Italy Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 78. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 79. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 80. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Region (2021-2032)
Figure 81. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Region (2021-2032)
Figure 82. China Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Japan Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 84. South Korea Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 85. India Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 86. Southeast Asia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 87. Australia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 88. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 89. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 90. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 91. South America Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 92. Brazil Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 93. Argentina Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 94. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 95. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 96. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 97. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 98. Turkey Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 99. Egypt Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 100. Saudi Arabia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 101. South Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 102. Immunoisolation Cell Encapsulation Device Market Drivers
Figure 103. Immunoisolation Cell Encapsulation Device Market Restraints
Figure 104. Immunoisolation Cell Encapsulation Device Market Trends
Figure 105. Porters Five Forces Analysis
Figure 106. Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device in 2025
Figure 107. Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
Figure 108. Immunoisolation Cell Encapsulation Device Industrial Chain
Figure 109. Sales Channel: Direct to End-User vs Distributors
Figure 110. Direct Channel Pros & Cons
Figure 111. Indirect Channel Pros & Cons
Figure 112. Methodology
Figure 113. Research Process and Data Source
Figure 1. Immunoisolation Cell Encapsulation Device Picture
Figure 2. Global Immunoisolation Cell Encapsulation Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type in 2025
Figure 4. Microcapsule Encapsulation Devices Examples
Figure 5. Sheet and Pouch Macroencapsulation Devices Examples
Figure 6. Hollow-Fiber Encapsulation Devices Examples
Figure 7. Chamber Encapsulation Devices Examples
Figure 8. Conformal Coating Encapsulation Devices Examples
Figure 9. Global Immunoisolation Cell Encapsulation Device Revenue by Immunoisolation Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism in 2025
Figure 11. Size-Selective Semipermeable Membrane Examples
Figure 12. Hydrogel Matrix Barrier Examples
Figure 13. Cellulose Sulfate Polymer Capsule Examples
Figure 14. Local Immunomodulation Barrier Examples
Figure 15. Nanoporous Membrane Barrier Examples
Figure 16. Global Immunoisolation Cell Encapsulation Device Revenue by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source in 2025
Figure 18. Human Donor Islets Examples
Figure 19. Stem Cell-Derived Islet Cells Examples
Figure 20. Porcine Islet Cells Examples
Figure 21. Engineered Therapeutic Cells Examples
Figure 22. Stem Cells and Stromal Cells Examples
Figure 23. Other Therapeutic Cells Examples
Figure 24. Global Immunoisolation Cell Encapsulation Device Revenue by Oxygenation and Vascularization Design, (USD Million), 2021 & 2025 & 2032
Figure 25. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design in 2025
Figure 26. Passive Diffusion Design Examples
Figure 27. Prevascularized Design Examples
Figure 28. Oxygen-Refueled Design Examples
Figure 29. Oxygen-Generating Design Examples
Figure 30. Port-Accessible Refillable Design Examples
Figure 31. Global Immunoisolation Cell Encapsulation Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application in 2025
Figure 33. Type 1 Diabetes Cell Therapy Examples
Figure 34. Metabolic and Endocrine Replacement Examples
Figure 35. Protein and Enzyme Delivery Examples
Figure 36. Cancer Local Cell Therapy Examples
Figure 37. Cell Therapy R&D and Preclinical Evaluation Examples
Figure 38. Bioreactor Cell Protection Examples
Figure 39. Other Applications Examples
Figure 40. Global Immunoisolation Cell Encapsulation Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 41. Global Immunoisolation Cell Encapsulation Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 42. Global Immunoisolation Cell Encapsulation Device Sales Quantity (2021-2032) & (Units)
Figure 43. Global Immunoisolation Cell Encapsulation Device Price (2021-2032) & (US$/Unit)
Figure 44. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Manufacturer in 2025
Figure 45. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Manufacturer in 2025
Figure 46. Producer Shipments of Immunoisolation Cell Encapsulation Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 47. Top 3 Immunoisolation Cell Encapsulation Device Manufacturer (Revenue) Market Share in 2025
Figure 48. Top 6 Immunoisolation Cell Encapsulation Device Manufacturer (Revenue) Market Share in 2025
Figure 49. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Region (2021-2032)
Figure 50. Global Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Region (2021-2032)
Figure 51. North America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 52. Europe Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 53. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 55. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 56. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 57. Global Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Type (2021-2032)
Figure 58. Global Immunoisolation Cell Encapsulation Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 59. Global Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 60. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application (2021-2032)
Figure 61. Global Immunoisolation Cell Encapsulation Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 62. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 63. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 64. North America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 65. North America Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 66. United States Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Canada Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Mexico Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 69. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 70. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 71. Europe Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 72. Europe Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 73. Germany Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 74. France Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 75. United Kingdom Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Russia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 77. Italy Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 78. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 79. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 80. Asia-Pacific Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Region (2021-2032)
Figure 81. Asia-Pacific Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Region (2021-2032)
Figure 82. China Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Japan Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 84. South Korea Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 85. India Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 86. Southeast Asia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 87. Australia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 88. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 89. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 90. South America Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 91. South America Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 92. Brazil Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 93. Argentina Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 94. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Type (2021-2032)
Figure 95. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Application (2021-2032)
Figure 96. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Quantity Market Share by Country (2021-2032)
Figure 97. Middle East & Africa Immunoisolation Cell Encapsulation Device Consumption Value Market Share by Country (2021-2032)
Figure 98. Turkey Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 99. Egypt Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 100. Saudi Arabia Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 101. South Africa Immunoisolation Cell Encapsulation Device Consumption Value (2021-2032) & (USD Million)
Figure 102. Immunoisolation Cell Encapsulation Device Market Drivers
Figure 103. Immunoisolation Cell Encapsulation Device Market Restraints
Figure 104. Immunoisolation Cell Encapsulation Device Market Trends
Figure 105. Porters Five Forces Analysis
Figure 106. Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device in 2025
Figure 107. Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
Figure 108. Immunoisolation Cell Encapsulation Device Industrial Chain
Figure 109. Sales Channel: Direct to End-User vs Distributors
Figure 110. Direct Channel Pros & Cons
Figure 111. Indirect Channel Pros & Cons
Figure 112. Methodology
Figure 113. Research Process and Data Source
